Immune Design Corp - Delisted Stock
Immune Design Corp cannot be verified against its exchange. It appears that Immune Design is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Note that a delisted financial instrument is a security that has been removed from its exchange and is no longer traded publicly. This can occur for various reasons, such as bankruptcy, merger, or failure to meet exchange listing requirements. Delisted instruments can still trade in the over-the-counter (OTC) market, but they are typically less liquid and carry higher risk compared to assets listed on a major exchange. Check all delisted instruments accross multiple markets.
Try Other Suggestions
Immune Design Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immune Design stock to make a market-neutral strategy. Peer analysis of Immune Design could also be used in its relative valuation, which is a method of valuing Immune Design by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Immune Design Corporate Directors
Immune Design corporate directors refer to members of an Immune Design board of directors. The board of directors generally takes responsibility for the Immune Design's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Immune Design's board members must vote for the resolution. The Immune Design board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Susan Kelley | Director | Profile | |
Brian Atwood | Independent Director | Profile | |
Lewis Coleman | Director | Profile | |
Franklin Berger | Independent Director | Profile |
Still Interested in Immune Design Corp?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Immune Design Corp information on this page should be used as a complementary analysis to other Immune Design's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Immune Stock
If you are still planning to invest in Immune Design Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immune Design's history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |